Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Expo West In Brief

This article was originally published in The Tan Sheet

Executive Summary

Horizon milk with DHA: Martek Bioscience has entered into a new agreement with Dean Foods Company's WhiteWave Foods subsidiary that will add Martek's life'sDHA to the Horizon Organic milk and new Rachel's natural yogurt brand products, the algal DHA firm announces March 9. The products are expected to debut in mid-2007, Martek notes. Under the 15-year deal, Dean and WhiteWave will purchase all their DHA omega-3 needs from Martek for products in the U.S. and other designated territories. "I believe that this agreement with Dean will serve as an important step forward towards the widespread use of Martek's life'sDHA in a variety of food and beverage products," Martek CEO Steve Dubin says. A previous agreement between the firms added life'sDHA in Silk Plus Omega-3 DHA soy milk (1"The Tan Sheet" Feb. 5, 2007, In Brief). At the show, WhiteWave also introduced Silk Plus Fiber and the Rachel's line of premium natural yogurts, which will be available nationwide in select channels...

You may also be interested in...



Martek Revenues Grow On International Demand For life’sDHA

Sales of life'sDHA to international infant formula manufacturers helped drive nutritional oil developer Martek Biosciences' revenue up 18 percent to a record $82.9 million during its fiscal 2008 first quarter, the firm says

Martek Revenues Grow On International Demand For life’sDHA

Sales of life'sDHA to international infant formula manufacturers helped drive nutritional oil developer Martek Biosciences' revenue up 18 percent to a record $82.9 million during its fiscal 2008 first quarter, the firm says

Martek Revenues Grow On International Demand For life’sDHA

Sales of life'sDHA to international infant formula manufacturers helped drive nutritional oil developer Martek Biosciences' revenue up 18 percent to a record $82.9 million during its fiscal 2008 first quarter, the firm says

Topics

UsernamePublicRestriction

Register

LL033172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel